Zolasartan
- Level
- Commodity
- Parent
- 51434800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51434821This classification denotes an angiotensin ii receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6NA6UHB9SW. European Medicines Agency schedules Zolasartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00174MIG. Zolasartan generally arises in the molecular formula C24H20BRCLN6O3. The term ZOLASARTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 no. 3 1994, list 34.) ZOLASARTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zolasartan under HS 29349990 and SITC 51579. As of Q4 2014, ZOLASARTAN remains the US FDA Preferred Term for this commodity. Zolasartan bears US NLM identifiers UMLS ID C0211676 and NCI Concept Code C66702. SMILES: CCCCC1=NC(=C(N1CC2=CC3=C(C=C2)OC(=C3Br)C4=CC=CC=C4C5=NNN=N5)C(=O)O)Cl.
Same parent
Under 51434800 · 21Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.